HOOKIPA Pharma (NASDAQ:HOOK) Trading 0.8% Higher – Still a Buy?

HOOKIPA Pharma Inc. (NASDAQ:HOOK)’s stock price was up 0.8% during mid-day trading on Tuesday . The company traded as high as $1.20 and last traded at $1.19. Approximately 6,162 shares traded hands during mid-day trading, a decline of 45% from the average daily volume of 11,190 shares. The stock had previously closed at $1.18.

HOOKIPA Pharma Trading Up 0.8%

The stock has a 50 day simple moving average of $1.09 and a 200-day simple moving average of $0.98. The firm has a market cap of $14.67 million, a P/E ratio of -0.20 and a beta of 0.84.

About HOOKIPA Pharma

HOOKIPA Pharma Inc is a clinical-stage biotechnology company focused on the development of virus-based immunotherapies and vaccines. The company operates two complementary platform technologies—an engineered Modified Vaccinia Ankara (MVA) vector and an arenavirus vector system—designed to stimulate both humoral and cellular immune responses. By combining these platforms, HOOKIPA aims to address infectious diseases and drive novel immuno-oncology treatments.

In the infectious disease arena, HOOKIPA’s pipeline includes prophylactic vaccine candidates targeting pathogens such as cytomegalovirus (CMV) in transplant settings and other viral threats.